Form 4: Cigna CEO David Cordani Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Cigna Group's CEO, David Cordani, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- David Cordani, the Chairman and CEO of Cigna Group, executed stock options and sold shares of Cigna common stock between March 12 and March 14, 2024.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2023.
- Cordani exercised options to purchase a total of 23,615 shares at a price of $139.22 per share.
- He then sold a total of 15,999 shares at prices ranging from approximately $345.00 to $348.66 per share.
- Following these transactions, Cordani directly owns 340,438 shares of Cigna common stock.
- Cordani also indirectly owns 1,727.2938 shares through a 401(k) plan, 99,918 shares through a GRAT, and 153,801 shares through a trust.
- He continues to hold options to purchase 47,601 shares of Cigna common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports transactions under a pre-existing trading plan, which is a normal part of executive compensation. There is no indication of positive or negative implications for the company.
Positives
- The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Industry Context
Insider transactions are common and closely monitored, especially those of key executives like the CEO. The use of a 10b5-1 plan indicates a pre-planned strategy for these transactions.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a significant component.
- The exercise and sale of shares by executives are typical, especially under pre-arranged trading plans like Rule 10b5-1.
- Comparable companies such as UnitedHealth Group (UNH) and Anthem (now Elevance Health) also see similar insider trading activity.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 03/01/2016 | Date the employee stock option was granted. |
| 03/01/2017 | First vesting date of the employee stock option. |
| 05/15/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| 03/12/2024 | Date of the earliest transaction reported. |
| 03/14/2024 | Date of the last transaction reported. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.